GlassScriptPhysician profile
Paul Harvey Holcomb
NPI 1518946912
$11,555.18
in general payments reported to CMS, 2019-2025
41 companies · $2,846 in 2025
The $2,846 reported for 2025 was more than what 88% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,174 · 2020: $781 · 2021: $1,398 · 2022: $2,102 · 2023: $1,523 · 2024: $1,731 · 2025: $2,846.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,837 · Travel and Lodging: $1,243 · Education: $20.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,836.90 |
| Travel and Lodging | $1,243.35 |
| Education | $20.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,923.15 | 2021-2025 | Micra, Ffrangio, Linq II |
| Novartis Pharmaceuticals Corporation | $1,464.92 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,278.81 | 2019-2025 | Lifevest |
| Pfizer INC. | $632.57 | 2019-2025 | |
| Edwards Lifesciences Corporation | $606.01 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $606.00 | 2019-2024 | Xarelto |
| Amgen INC. | $537.24 | 2019-2025 | Repatha, Repatha |
| Abiomed | $526.29 | 2019-2024 | Impella |
| Abbott Laboratories | $483.57 | 2021-2025 | Xience Skypoint, Nc Trek Neo |
| Actelion Pharmaceuticals US, INC. | $439.56 | 2019-2023 | Uptravi, Opsumit |
| E.R. Squibb & Sons, L.L.C. | $391.05 | 2019-2025 | Camzyos, Eliquis |
| Boston Scientific Corporation | $362.28 | 2020-2025 | Watchman Flx, Bodyguardian, Watchman |
| Merck Sharp & Dohme LLC | $320.08 | 2021-2024 | Verquvo |
| Sanofi-Aventis U.S. LLC | $262.32 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $253.20 | 2019-2023 | Jardiance |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $188.93 | 2019-2023 | Farxiga |
| Cvrx, INC. | $174.38 | 2023-2024 | Barostim Neo System |
| Amarin Pharma, INC. | $148.44 | 2021-2022 | |
| Irhythm Technologies, INC. | $91.92 | 2019-2023 | Zio Xt Patch |
| Acist Medical Systems, INC. | $90.19 | 2023 | |
| Baxter Healthcare | $81.62 | 2023 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Inspire Medical Systems, INC. | $70.68 | 2024-2025 | Inspire |
| Ge Healthcare | $60.11 | 2021-2023 | |
| Biotronik INC. | $58.57 | 2020-2022 | |
| Preventice Services, LLC | $52.21 | 2021 | |
| Philips North America LLC | $51.77 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Kiniksa Pharmaceuticals International, Plc | $45.94 | 2024 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $43.33 | 2022-2023 | |
| Astellas Pharma US INC | $41.66 | 2019-2021 | |
| Atricure, INC. | $35.46 | 2024 | |
| Elutia, INC. | $34.35 | 2019-2021 | |
| Esperion Therapeutics, INC. | $32.35 | 2024 | Nexletol |
| Zoll Circulation INC | $30.30 | 2022 | |
| Cardinal Health 200 LLC | $29.13 | 2019 | |
| Alnylam Pharmaceuticals INC. | $17.85 | 2022 | |
| Daiichi Sankyo INC. | $16.03 | 2019 | |
| Inogen, INC. | $15.81 | 2022 | |
| Medtronic Vascular, INC. | $15.44 | 2020 | |
| Altathera Pharmaceuticals LLC | $15.05 | 2025 | Sotalol Hydrochloride |
| Cordis US Corp. | $13.88 | 2021 | |
| Cardiovascular Systems INC. | $12.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Holcomb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.